Literature DB >> 8099627

Chicken adenovirus (CELO virus) particles augment receptor-mediated DNA delivery to mammalian cells and yield exceptional levels of stable transformants.

M Cotten1, E Wagner, K Zatloukal, M L Birnstiel.   

Abstract

Delivery of genes via receptor-mediated endocytosis is severely limited by the poor exit of endocytosed DNA from the endosome. A large enhancement in delivery efficiency has been obtained by including human adenovirus particles in the delivery system. This enhancement is probably a function of the natural adenovirus entry mechanism, which must include passage through or disruption of the endosomal membrane. In an effort to identify safer virus particles useful in this application, we have tested the chicken adenovirus CELO virus for its ability to augment receptor-mediated gene delivery. We report here that CELO virus possesses pH-dependent, liposome disruption activity similar to that of human adenovirus type 5. Furthermore, the chicken adenovirus can be used to augment receptor-mediated gene delivery to levels comparable to those found for the human adenovirus when it is physically linked to polylysine ligand-condensed DNA particles. The chicken adenovirus has the advantage of being produced inexpensively in embryonated eggs, and the virus is naturally replication defective in mammalian cells, even in the presence of wild-type human adenovirus.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8099627      PMCID: PMC237742     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

1.  Observations on a chicken embryo lethal orphan (CELO) virus.

Authors:  V J YATES; D E FRY
Journal:  Am J Vet Res       Date:  1957-07       Impact factor: 1.156

2.  Sequence of an avian adenovirus (CELO) DNA fragment (0-11.2%)

Authors:  T A Akopian; V A Kruglyak; M B Rivkina; B S Naroditsky; T I Tikhonenko
Journal:  Nucleic Acids Res       Date:  1990-05-11       Impact factor: 16.971

3.  Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells.

Authors:  M Zenke; P Steinlein; E Wagner; M Cotten; H Beug; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

4.  Nonpermissivity of human peripheral blood lymphocytes to adenovirus type 2 infection.

Authors:  J Horvath; J M Weber
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

5.  Construction of plasmids that express E. coli beta-galactosidase in mammalian cells.

Authors:  G R MacGregor; C T Caskey
Journal:  Nucleic Acids Res       Date:  1989-03-25       Impact factor: 16.971

6.  Regulation of endocytic pH by the Na+,K+-ATPase in living cells.

Authors:  C C Cain; D M Sipe; R F Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

7.  Chicken embryo propagation of type I avian adenoviruses.

Authors:  B S Cowen
Journal:  Avian Dis       Date:  1988 Apr-Jun       Impact factor: 1.577

8.  A simple assay for DNA transfection by incubation of the cells in culture dishes with substrates for beta-galactosidase.

Authors:  K Lim; C B Chae
Journal:  Biotechniques       Date:  1989-06       Impact factor: 1.993

9.  Transferrin-polycation conjugates as carriers for DNA uptake into cells.

Authors:  E Wagner; M Zenke; M Cotten; H Beug; M L Birnstiel
Journal:  Proc Natl Acad Sci U S A       Date:  1990-05       Impact factor: 11.205

10.  Interaction of human adenovirus serotype 2 with human lymphoid cells.

Authors:  L Silver; C W Anderson
Journal:  Virology       Date:  1988-08       Impact factor: 3.616

View more
  18 in total

Review 1.  Nonneurotropic adenovirus: a vector for gene transfer to the brain and gene therapy of neurological disorders.

Authors:  Pedro R Lowenstein; Donata Suwelack; Jinwei Hu; Xianpeng Yuan; Maximiliano Jimenez-Dalmaroni; Shyam Goverdhana; Maria G Castro
Journal:  Int Rev Neurobiol       Date:  2003       Impact factor: 3.230

2.  Nanoporous crystals of chicken embryo lethal orphan (CELO) adenovirus major coat protein, hexon.

Authors:  Lan Xu; Stacy D Benson; Roger M Burnett
Journal:  J Struct Biol       Date:  2006-09-14       Impact factor: 2.867

Review 3.  Current aspects of gene therapy: implications for vascular interventions.

Authors:  F Reifers; J Kreuzer
Journal:  J Mol Med (Berl)       Date:  1995-12       Impact factor: 4.599

Review 4.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

5.  Cellular uptake and infection by canine parvovirus involves rapid dynamin-regulated clathrin-mediated endocytosis, followed by slower intracellular trafficking.

Authors:  J S Parker; C R Parrish
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

6.  The complete DNA sequence and genomic organization of the avian adenovirus CELO.

Authors:  S Chiocca; R Kurzbauer; G Schaffner; A Baker; V Mautner; M Cotten
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

7.  A recombinant bcl-x s adenovirus selectively induces apoptosis in cancer cells but not in normal bone marrow cells.

Authors:  M F Clarke; I J Apel; M A Benedict; P G Eipers; V Sumantran; M González-García; M Doedens; N Fukunaga; B Davidson; J E Dick; A J Minn; L H Boise; C B Thompson; M Wicha; G Núñez
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

Review 8.  Delivery of DNA into mammalian cells by receptor-mediated endocytosis and gene therapy.

Authors:  J Guy; D Drabek; M Antoniou
Journal:  Mol Biotechnol       Date:  1995-06       Impact factor: 2.695

9.  Mutational analysis of the avian adenovirus CELO, which provides a basis for gene delivery vectors.

Authors:  A I Michou; H Lehrmann; M Saltik; M Cotten
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  Mechanism of enhancement of DNA expression consequent to cointernalization of a replication-deficient adenovirus and unmodified plasmid DNA.

Authors:  P Seth; M Rosenfeld; J Higginbotham; R G Crystal
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.